Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β.
作者信息
Vinh Donald C, Abel Laurent, Bastard Paul, Cheng Matthew P, Condino-Neto Antonio, Gregersen Peter K, Haerynck Filomeen, Cicalese Maria-Pia, Hagin David, Soler-Palacín Pere, Planas Anna M, Pujol Aurora, Notarangelo Luigi D, Zhang Qian, Su Helen C, Casanova Jean-Laurent, Meyts Isabelle
机构信息
McGill University Health Centre, Montreal, Canada.
St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, 10065, USA.
出版信息
J Clin Immunol. 2021 Oct;41(7):1425-1442. doi: 10.1007/s10875-021-01068-6. Epub 2021 Jun 8.
Abstract
摘要
相似文献
1
Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β.
J Clin Immunol. 2021 Oct;41(7):1425-1442. doi: 10.1007/s10875-021-01068-6. Epub 2021 Jun 8.
2
Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis.
J Allergy Clin Immunol. 2021 Jul;148(1):96-98. doi: 10.1016/j.jaci.2021.03.034. Epub 2021 Apr 16.
3
Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma.
J Clin Immunol. 2021 Aug;41(6):1169-1171. doi: 10.1007/s10875-021-01060-0. Epub 2021 May 19.
4
Flawed interferon response spurs severe illness.
Science. 2020 Sep 25;369(6511):1550-1551. doi: 10.1126/science.369.6511.1550.
5
Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH).
Med Intensiva (Engl Ed). 2021 Mar;45(2):104-121. doi: 10.1016/j.medin.2020.06.017. Epub 2020 Jul 11.
6
Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis.
Front Immunol. 2021 Jun 30;12:711915. doi: 10.3389/fimmu.2021.711915. eCollection 2021.
7
Harnessing immunotherapy to combat COVID-19: A modern snake oil or silver bullet?
Therapie. 2021 Jul-Aug;76(4):335-345. doi: 10.1016/j.therap.2020.10.004. Epub 2020 Nov 1.
8
Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell Therapy.
Front Immunol. 2021 Aug 12;12:721738. doi: 10.3389/fimmu.2021.721738. eCollection 2021.
9
Google Trends demonstrate public interest in COVID-19 convalescent plasma therapy.
J Clin Apher. 2021 Jun;36(3):492-493. doi: 10.1002/jca.21862. Epub 2020 Dec 19.
10
Exploring the multifocal therapeutic approaches in COVID-19: A ray of hope.
Int Immunopharmacol. 2021 Jan;90:107156. doi: 10.1016/j.intimp.2020.107156. Epub 2020 Nov 3.
引用本文的文献
1
GIGYF2: A Multifunctional Regulator at the Crossroads of Gene Expression, mRNA Surveillance, and Human Disease.
Cells. 2025 Jul 5;14(13):1032. doi: 10.3390/cells14131032.
2
A Thermosensitive and Degradable Chitin-Based Hydrogel as a Brucellosis Vaccine Adjuvant.
Polymers (Basel). 2024 Oct 4;16(19):2815. doi: 10.3390/polym16192815.
3
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.
J Exp Med. 2024 Feb 5;221(2). doi: 10.1084/jem.20231353. Epub 2024 Jan 4.
4
Lipin-2 regulates the antiviral and anti-inflammatory responses to interferon.
EMBO Rep. 2023 Dec 6;24(12):e57238. doi: 10.15252/embr.202357238. Epub 2023 Nov 6.
5
Protective versus Pathogenic Type I Interferon Responses during Virus Infections.
Viruses. 2023 Sep 13;15(9):1916. doi: 10.3390/v15091916.
6
Blockade of interferon signaling decreases gut barrier integrity and promotes severe West Nile virus disease.
Nat Commun. 2023 Sep 25;14(1):5973. doi: 10.1038/s41467-023-41600-3.
7
Anti-cytokine autoantibodies: mechanistic insights and disease associations.
Nat Rev Immunol. 2024 Mar;24(3):161-177. doi: 10.1038/s41577-023-00933-2. Epub 2023 Sep 19.
8
Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles.
Sci Rep. 2023 Aug 7;13(1):12784. doi: 10.1038/s41598-023-39681-7.
9
Interferon at the crossroads of SARS-CoV-2 infection and COVID-19 disease.
J Biol Chem. 2023 Aug;299(8):104960. doi: 10.1016/j.jbc.2023.104960. Epub 2023 Jun 24.
10
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients.
J Exp Med. 2023 Sep 4;220(9). doi: 10.1084/jem.20230661. Epub 2023 Jun 22.
本文引用的文献
1
Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients.
Clin Transl Immunology. 2021 Aug 17;10(8):e1327. doi: 10.1002/cti2.1327. eCollection 2021.
2
Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma.
J Clin Immunol. 2021 Aug;41(6):1169-1171. doi: 10.1007/s10875-021-01060-0. Epub 2021 May 19.
3
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
Cell. 2021 Apr 29;184(9):2523. doi: 10.1016/j.cell.2021.04.006.
4
Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain.
J Clin Immunol. 2021 Jul;41(5):914-922. doi: 10.1007/s10875-021-01036-0. Epub 2021 Apr 13.
5
Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients.
Intensive Care Med. 2021 Jun;47(6):704-706. doi: 10.1007/s00134-021-06392-4. Epub 2021 Apr 9.
6
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial.
Nat Commun. 2021 Mar 30;12(1):1967. doi: 10.1038/s41467-021-22177-1.
7
Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway.
Eur J Immunol. 2021 May;51(5):1039-1061. doi: 10.1002/eji.202048793. Epub 2021 Apr 4.
8
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study.
BMJ. 2021 Mar 9;372:n579. doi: 10.1136/bmj.n579.
9
A COVID-19 pregnant patient with thrombotic thrombocytopenic purpura: a case report.
J Med Case Rep. 2021 Mar 1;15(1):104. doi: 10.1186/s13256-020-02577-5.
10
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.
N Engl J Med. 2021 Apr 22;384(16):1503-1516. doi: 10.1056/NEJMoa2028700. Epub 2021 Feb 25.
Zotero 插件